NCT03590730 - Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

July 10, 2019

Study Completion Date

July 15, 2021

Conditions

Valvular Heart DiseaseImplantable Cardioverter DefibrillatorSudden Cardiac DeathPrimary Prevention

Interventions

DEVICE

ICD implantation

ICD will be implanted according to current guidelines recommendations.

Trial Locations (12)

Seoul National University Bundang Hospital, Seongnam

Mediplex Sejong Hospital, Incheon

Division of Cardiology, Department of Internal Medicine, Kyungpook National University Hospital, Daegu

Division of Cardiology, Department of Internal Medicine, Yeungnam University Hospital, Daegu

Pusan National University Yangsan Hospital, Yangsan

Chonnam National University Hospital, Gwangju

Korea University Anam Hospital, Seoul

Seoul National University Hospital, Seoul

Severance Cardiovascular Hospital, Seoul

Seoul Asan Medical Center, Seoul

Seoul Samsung Medical Center, Seoul

Seoul St. Mary's Hospital, Seoul